Disruption of the selenocysteine lyase-mediated selenium recycling pathway leads to metabolic syndrome in mice

Molecular and Cellular Biology

Volumn 32, Issue 20, 2012, Pages 4141-4154

  Seale, Lucia A ^a   Hashimoto, Ann C ^a   Kurokawa, Suguru ^a   Gilman, Christy L ^a   Seyedali, Ali ^a   Bellinger, Frederick P ^a   Raman, Arjun V ^a   Berry, Marla J ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; AMP KINASE ALPHA; GLUCOSE; GLUTATHIONE PEROXIDASE 1; INSULIN; LIPID; LYASE; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE 1B; SELENIUM; SELENOCYSTEINE LYASE; SELENOPROTEIN; SELENOPROTEIN P; SELENOPROTEIN S; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; CONTROLLED STUDY; DIET RESTRICTION; ENZYME PHOSPHORYLATION; FATTY LIVER; FEMALE; GENE INACTIVATION; GLUCOSE INTOLERANCE; HYPERCHOLESTEROLEMIA; HYPERINSULINEMIA; HYPERLEPTINEMIA; MALE; METABOLIC SYNDROME X; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; FATTY LIVER; GLUCOSE INTOLERANCE; GLUTATHIONE PEROXIDASE; HYPERCHOLESTEROLEMIA; HYPERINSULINISM; LEPTIN; LYASES; MALE; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; OXIDATIVE STRESS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; PROTO-ONCOGENE PROTEINS C-AKT; SELENIUM; SELENOPROTEINS;

ANIMALIA; MUS;

EID: 84868690957     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00293-12     Document Type: Article

References (66)

1. Bjorbaek C, El-Haschimi K, Frantz JD, Flier JS. 1999. The role of SOCS-3 in leptin signaling and leptin resistance. J. Biol. Chem. 274: 30059-30065.
2. Boitani C, Puglisi R. 2008. Selenium, a key element in spermatogenesis and male fertility. Adv. Exp. Med. Biol. 636:65-73.
3. Burk RF, Hill KE. 2009. Selenoprotein P-expression, functions, and roles in mammals. Biochim. Biophys. Acta 1790:1441-1447.
4. Burk RF, Hill KE. 2005. Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annu. Rev. Nutr. 25:215-235.
5. Burk RF, et al. 2007. Deletion of apolipoprotein E receptor-2 in mice lowers brain selenium and causes severe neurological dysfunction and death when a low-selenium diet is fed. J. Neurosci. 27:6207- 6211.
6. Chanoine JP, Wong AC, Lavoie JC. 2004. Selenium deficiency impairs corticosterone and leptin responses to adrenocorticotropin in the rat. Biofactors 20:109 -118.
7. Chen J, Berry MJ. 2003. Selenium and selenoproteins in the brain and brain diseases. J. Neurochem. 86:1-12.
8. Clarke NF, et al. 2006. SEPN1: associated with congenital fiber-type disproportion and insulin resistance. Ann. Neurol. 59:546 -552.
9. Cohen JC, Horton JD, Hobbs HH. 2011. Human fatty liver disease: old questions and new insights. Science 332:1519 -1523.
10. Collins R, et al. 2012. Biochemical discrimination between selenium and sulfur 1: a single residue provides selenium specificity to human selenocysteine lyase. PLoS One 7:e30581. doi:10.1371/journal.pone.0030581.
11. Combs GF, Jr, et al. 2011. Determinants of selenium status in healthy adults. Nutr. J. 10:75. doi:10.1186/1475-2891-10-75.
12. Copeland PR, Fletcher JE, Carlson BA, Hatfield DL, Driscoll DM. 2000. A novel RNA binding protein, SBP2, is required for the translation of mammalian selenoprotein mRNAs. EMBO J. 19:306 -314.
13. Cypess AM, Kahn CR. 2010. The role and importance of brown adipose tissue in energy homeostasis. Curr. Opin. Pediatr. 22:478-484.
14. Davies BS, Beigneux AP, Fong LG, Young SG. 2012. New wrinkles in lipoprotein lipase biology. Curr. Opin. Lipidol 23:35- 42.
15. Deagen JT, Butler JA, Beilstein MA, Whanger PD. 1987. Effects of dietary selenite, selenocystine and selenomethionine on selenocysteine lyase and glutathione peroxidase activities and on selenium levels in rat tissues. J. Nutr. 117:91-98.
16. Du JL, et al. 2008. Association of SelS mRNA expression in omental adipose tissue with Homa-IR and serum amyloid A in patients with type 2 diabetes mellitus. Chin. Med. J. (Engl.) 121:1165-1168.
17. Eckel RH, et al. 2011. Obesity and type 2 diabetes: what can be unified and what needs to be individualized? J. Clin. Endocrinol. Metab. 96:1654- 1663.
18. Esaki N, Nakamura T, Tanaka H, Soda K. 1982. Selenocysteine lyase, a novel enzyme that specifically acts on selenocysteine. Mammalian distribution and purification and properties of pig liver enzyme. J. Biol. Chem. 257:4386-4391.
19. Flohe L. 2007. Selenium in mammalian spermiogenesis. Biol. Chem. 388: 987-995.
20. Gao Y, et al. 2007. Secretion of the glucose-regulated selenoprotein SEPS1 from hepatoma cells. Biochem. Biophys. Res. Commun. 356:636-641.
21. Ghosh S, et al. 2010. Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. Hepat. Med. 2010:69 -78.
22. Hill KE, et al. 2007. The selenium-rich C-terminal domain of mouse selenoprotein P is necessary for the supply of selenium to brain and testis but not for the maintenance of whole body selenium. J. Biol. Chem. 282: 10972-10980.
23. Hill KE, et al. 2003. Deletion of selenoprotein P alters distribution of selenium in the mouse. J. Biol. Chem. 278:13640 -13646.
24. Hoffmann FW, et al. 2010. Dietary selenium modulates activation and differentiation of CD4 T cells in mice through a mechanism involving cellular free thiols. J. Nutr. 140:1155-1161.
25. Hoffmann PR, et al. 2007. The selenoproteome exhibits widely varying, tissue-specific dependence on selenoprotein P for selenium supply. Nucleic Acids Res. 35:3963-3973.
26. Hwang JT, et al. 2006. Selenium regulates cyclooxygenase-2 and extracellular signal-regulated kinase signaling pathways by activating AMPactivated protein kinase in colon cancer cells. Cancer Res. 66:10057- 10063.
27. Kim KH. 1997. Regulation of mammalian acetyl-coenzyme A carboxylase. Annu. Rev. Nutr. 17:77-99.
28. Kim SS, et al. 2011. Exercise training and selenium or a combined treatment ameliorates aberrant expression of glucose and lactate metabolic proteins in skeletal muscle in a rodent model of diabetes. Nutr. Res. Pract. 5:205-213.
29. Klein EA, et al. 2011. Vitamin E and the risk of prostate cancer: the selenium and vitamin E cancer prevention trial (SELECT). JAMA 306: 1549-1556.
30. Kurokawa S, et al. 2011. Mammalian selenocysteine lyase is involved in selenoprotein biosynthesis. J. Nutr. Sci. Vitaminol. (Tokyo) 57:298 -305.
31. Ledesma MC, et al. 2011. Selenium and vitamin E for prostate cancer: post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) status. Mol. Med. 17:134 -143.
32. Lei XG, Cheng WH. 2005. New roles for an old selenoenzyme: evidence from glutathione peroxidase-1 null and overexpressing mice. J. Nutr. 135: 2295-2298.
33. Lei XG, Vatamaniuk MZ. 2011. Two tales of antioxidant enzymes on beta cells and diabetes. Antioxid. Redox. Signal. 14:489 -503.
34. Leinninger GM. 2009. Location, location, location: the CNS sites of leptin action dictate its regulation of homeostatic and hedonic pathways. Int. J. Obes. (Lond.) 33(Suppl. 2):S14 -S17.
35. Lippman SM, et al. 2009. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301:39 -51.
36. Low SC, Berry MJ. 1996. Knowing when not to stop: selenocysteine incorporation in eukaryotes. Trends Biochem. Sci. 21:203-208.
37. Marsili A, et al. 2011. Mice with a targeted deletion of the type 2 deiodinase are insulin resistant and susceptible to diet induced obesity. PLoS One 6:e20832. doi:10.1371/journal.pone.0020832.
38. McClung JP, et al. 2004. Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase. Proc. Natl. Acad. Sci. U. S. A. 101:8852- 8857.
39. Medina MC, et al. 2011. The thyroid hormone-inactivating type III deiodinase is expressed in mouse and human β-cells and its targeted inactivation impairs insulin secretion. Endocrinology 152:3717-3727.
40. Merino B, Diez-Fernandez C, Ruiz-Gayo M, Somoza B. 2006. Choroid plexus epithelial cells co-express the long and short form of the leptin receptor. Neurosci. Lett. 393:269 -272.
41. Mihara H, Kurihara T, Watanabe T, Yoshimura T, Esaki N. 2000. cDNA cloning, purification, and characterization of mouse liver selenocysteine lyase. Candidate for selenium delivery protein in selenoprotein synthesis. J. Biol. Chem. 275:6195- 6200.
42. Misu H, et al. 2010. A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell Metab. 12:483- 495.
43. Muecke R, Schomburg L, Buentzel J, Kisters K, Micke O. 2010. Selenium or no selenium-that is the question in tumor patients: a new controversy. Integr. Cancer Ther. 9:136 -141.
44. Mueller AS, et al. 2009. Regulation of the insulin antagonistic protein tyrosine phosphatase 1B by dietary Se studied in growing rats. J. Nutr. Biochem. 20:235-247.
45. Mueller AS, et al. 2008. Redox regulation of protein tyrosine phosphatase 1B by manipulation of dietary selenium affects the triglyceride concentration in rat liver. J. Nutr. 138:2328 -2336.
46. Omi R, et al. 2010. Reaction mechanism and molecular basis for selenium/ sulfur discrimination of selenocysteine lyase. J. Biol. Chem. 285: 12133-12139.
47. Raman AV, et al. 2012. Absence of selenoprotein P but not selenocysteine lyase results in neurological dysfunction. Genes Brain Behav. 11:601- 613.
48. Rayman MP. 2008. Food-chain selenium and human health: emphasis on intake. Br. J. Nutr. 100:254 -268.
49. Rayman MP. 2000. The importance of selenium to human health. Lancet 356:233-241.
50. Ricart-Jane D, Cejudo-Martin P, Peinado-Onsurbe J, Lopez-Tejero MD, Llobera M. 2005. Changes in lipoprotein lipase modulate tissue energy supply during stress. J. Appl. Physiol. 99:1343-1351.
51. Riese C, et al. 2006. Selenium-dependent pre- and posttranscriptional mechanisms are responsible for sexual dimorphic expression of selenoproteins in murine tissues. Endocrinology 147:5883-5892.
52. Schomburg L, et al. 2003. Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochem. J. 370:397- 402.
53. Schweizer U, Brauer AU, Kohrle J, Nitsch R, Savaskan NE. 2004. Selenium and brain function: a poorly recognized liaison. Brain Res. Brain Res. Rev. 45:164 -178.
54. Small-Howard A, et al. 2006. Supramolecular complexes mediate selenocysteine incorporation in vivo. Mol. Cell. Biol. 26:2337-2346.
55. Speckmann B, et al. 2008. Selenoprotein P expression is controlled through interaction of the coactivator PGC-1α with FoxO1a and hepatocyte nuclear factor 4α transcription factors. Hepatology 48:1998 -2006.
56. Stranges S, et al. 2007. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann. Intern. Med. 147:217-223.
57. Tamura T, et al. 2004. Selenophosphate synthetase genes from lung adenocarcinoma cells: Sps1 for recycling L-selenocysteine and Sps2 for selenite assimilation. Proc. Natl. Acad. Sci. U. S. A. 101:16162-16167.
58. Tobe R, Mihara H, Kurihara T, Esaki N. 2009. Identification of proteins interacting with selenocysteine lyase. Biosci. Biotechnol. Biochem. 73: 1230-1232.
59. Wakil SJ, Abu-Elheiga LA. 2009. Fatty acid metabolism: target for metabolic syndrome. J. Lipid Res. 50(Suppl.):S138 -S143.
60. Wang KT, Wang J, Li LF, Su XD. 2009. Crystal structures of catalytic intermediates of human selenophosphate synthetase 1. J. Mol. Biol. 390: 747-759.
61. Xu XM, et al. 2007. Biosynthesis of selenocysteine on its tRNA in eukaryotes. PLoS Biol. 5:e4. doi:10.1371/journal.pbio.0050004.
62. Xu XM, et al. 2010. Targeted insertion of cysteine by decoding UGA codons with mammalian selenocysteine machinery. Proc. Natl. Acad. Sci. U. S. A. 107:21430 -21434.
63. Yang JG, Hill KE, Burk RF. 1989. Dietary selenium intake controls rat plasma selenoprotein P concentration. J. Nutr. 119:1010 -1012.
64. Yang SJ, et al. 2011. Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis. J. Clin. Endocrinol. Metab. 96:E1325- E1329.
65. Yeh JY, Ou BR, Gu QP, Whanger PD. 1998. Influence of gender on selenoprotein W, glutathione peroxidase and selenium in tissues of rats. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 119:151-155.
66. Zhao LF, et al. 2010. Hormonal regulation of acetyl-CoA carboxylase isoenzyme gene transcription. Endocr. J. 57:317-324.